LymeX Authorization Act

House Bill

H.R. 7482

119th Congress

LymeX Authorization Act

In Committee

Introduced:Feb 11, 2026

Primary Sponsor

Christopher Smith

R - NJ

Cosponsors

0

Quick Stats

Policy Area

Health

Summary

The LymeX Authorization Act would establish a federal initiative to combat Lyme disease, which affects an estimated 476,000 Americans annually. This bill aims to accelerate research, improve diagnostic tools, and develop better treatments for Lyme disease and other tick-borne illnesses that are increasingly spreading across the United States.

Latest Action

Referred to the House Committee on Energy and Commerce.

Introduced2/11/2026

StatusReferred to the House Committee on Energy and Commerce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

LymeX Authorization Act

The LymeX Authorization Act would establish a federal initiative to combat Lyme disease, which affects an estimated 476,000 Americans annually. This bill aims to accelerate research, improve diagnostic tools, and develop better treatments for Lyme disease and

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The LymeX Authorization Act would establish a federal initiative to combat Lyme disease, which affects an estimated 476,000 Americans annually. This bill aims to accelerate research, improve diagnostic tools, and develop better treatments for Lyme disease and other tick-borne illnesses that are increasingly spreading across the United States.

Bill Number: 7482
Introduced: 2/11/2026
Status: Referred to the House Committee on Energy and Commerce.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: LymeX Authorization Act
Bill Number: 7482
Sponsor: No sponsor
Status: Referred to the House Committee on Energy and Commerce.
Introduced: 2/11/2026
Summary: The LymeX Authorization Act would establish a federal initiative to combat Lyme disease, which affects an estimated 476,000 Americans annually. This bill aims to accelerate research, improve diagnostic tools, and develop better treatments for Lyme disease and other tick-borne illnesses that are incr

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

The LymeX Authorization Act would establish a federal initiative to combat Lyme disease, which affects an estimated 476,000 Americans annually. This bill aims to accelerate research, improve diagnostic tools, and develop better treatments for Lyme disease and other tick-borne illnesses that are increasingly spreading across the United States.

Last updated: 2/23/2026

Key Points

Main provisions of the bill

Authorizes federal funding and coordination for Lyme disease research, addressing a growing public health threat that has expanded to all 50 states
Would support development of faster, more accurate diagnostic tests to catch Lyme disease early when it's most treatable
Aims to create better treatment options for patients suffering from long-term Lyme disease symptoms, which can be debilitating
Addresses tick-borne diseases beyond just Lyme, including emerging threats as tick populations expand due to climate change

How This Impacts Americans

Potential effects on citizens and communities

This legislation would primarily benefit the estimated half-million Americans diagnosed with Lyme disease each year, particularly those in the Northeast, Upper Midwest, and expanding endemic areas. Outdoor workers, hikers, families in suburban areas near wooded regions, and rural communities would see improved access to prevention information, faster diagnoses, and more effective treatments. The bill could also reduce long-term healthcare costs associated with misdiagnosed or untreated Lyme disease cases.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

7482, 119th Congress (2026). "LymeX Authorization Act". Source: Voter's Right Platform. https://votersright.org/bills/119-hr-7482

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.